Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Short Interest Down 98.7% in March

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 1,800 shares, a decrease of 98.7% from the February 29th total of 141,600 shares. Based on an average trading volume of 3,144,000 shares, the days-to-cover ratio is presently 0.0 days.

Reckitt Benckiser Group Stock Up 2.0 %

Shares of RBGLY stock traded up $0.22 on Thursday, reaching $11.37. The company’s stock had a trading volume of 958,729 shares, compared to its average volume of 940,548. The stock’s 50 day simple moving average is $13.56 and its 200-day simple moving average is $13.76. Reckitt Benckiser Group has a 12-month low of $10.66 and a 12-month high of $16.60. The company has a current ratio of 0.54, a quick ratio of 0.36 and a debt-to-equity ratio of 0.57.

Reckitt Benckiser Group Increases Dividend

The company also recently announced a dividend, which will be paid on Monday, June 3rd. Shareholders of record on Friday, April 12th will be issued a dividend of $0.2701 per share. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.18. The ex-dividend date of this dividend is Thursday, April 11th.

Analysts Set New Price Targets

RBGLY has been the subject of a number of research reports. Jefferies Financial Group downgraded Reckitt Benckiser Group from a “hold” rating to an “underperform” rating in a report on Monday, December 11th. BNP Paribas raised Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a report on Tuesday, January 9th. Finally, Sanford C. Bernstein raised Reckitt Benckiser Group from a “market perform” rating to an “outperform” rating in a report on Monday, December 11th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $6,978.00.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.